Hill-Rom Holdings ROE 2006-2019 | HRC

Current and historical return on equity (ROE) values for Hill-Rom Holdings (HRC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Hill-Rom Holdings ROE for the three months ending September 30, 2019 was 21.67%.
Hill-Rom Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-09-30 $0.15B $1.57B 9.64%
2019-06-30 $0.22B $1.63B 13.45%
2019-03-31 $0.23B $1.60B 14.47%
2018-12-31 $0.21B $1.55B 13.32%
2018-09-30 $0.25B $1.62B 16.53%
2018-06-30 $0.23B $1.51B 15.80%
2018-03-31 $0.19B $1.51B 13.64%
2017-12-31 $0.20B $1.46B 14.66%
2017-09-30 $0.13B $1.37B 10.42%
2017-06-30 $0.12B $1.29B 9.33%
2017-03-31 $0.16B $1.25B 12.70%
2016-12-31 $0.14B $1.20B 11.90%
2016-09-30 $0.12B $1.24B 10.42%
2016-06-30 $0.06B $1.20B 5.30%
2016-03-31 $0.04B $1.18B 3.39%
2015-12-31 $0.04B $1.15B 4.22%
2015-09-30 $0.05B $1.16B 5.55%
2015-06-30 $0.08B $0.77B 10.79%
2015-03-31 $0.09B $0.72B 11.48%
2014-12-31 $0.06B $0.74B 7.54%
2014-09-30 $0.06B $0.81B 7.44%
2014-06-30 $0.07B $0.83B 8.52%
2014-03-31 $0.07B $0.80B 8.23%
2013-12-31 $0.09B $0.84B 11.23%
2013-09-30 $0.10B $0.86B 12.63%
2013-06-30 $0.11B $0.81B 13.30%
2013-03-31 $0.11B $0.81B 13.27%
2012-12-31 $0.11B $0.82B 13.69%
2012-09-30 $0.12B $0.81B 15.04%
2012-06-30 $0.15B $0.81B 18.58%
2012-03-31 $0.12B $0.80B 16.19%
2011-12-31 $0.13B $0.77B 17.45%
2011-09-30 $0.13B $0.74B 17.96%
2011-06-30 $0.12B $0.75B 16.40%
2011-03-31 $0.15B $0.76B 20.87%
2010-12-31 $0.14B $0.73B 20.41%
2010-09-30 $0.13B $0.71B 18.95%
2010-06-30 $0.10B $0.68B 15.78%
2010-03-31 $0.09B $0.65B 14.48%
2009-12-31 $-0.40B $0.63B -66.20%
2009-09-30 $-0.41B $0.61B -56.92%
2009-06-30 $-0.41B $0.60B -49.05%
2009-03-31 $-0.41B $0.58B -42.91%
2008-12-31 $0.08B $1.06B 7.86%
2008-09-30 $0.12B $1.08B 10.17%
2008-06-30 $0.14B $1.08B 11.79%
2008-03-31 $0.16B $1.05B 12.67%
2007-12-31 $0.18B $1.31B 14.55%
2007-09-30 $0.19B $1.28B 15.53%
2007-06-30 $0.21B $1.26B 17.59%
2007-03-31 $0.23B $1.22B 19.60%
2006-12-31 $0.23B $1.17B 20.40%
2006-09-30 $0.22B $1.13B 20.84%
2006-06-30 $-0.08B $1.07B -7.45%
2006-03-31 $-0.09B $1.04B -8.63%
2005-12-31 $-0.09B $1.00B -8.52%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.921B $2.907B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.763B 27.14
Medtronic (MDT) Ireland $146.524B 20.57
Stryker (SYK) United States $76.003B 25.56
Boston Scientific (BSX) United States $57.941B 27.35
Baxter (BAX) United States $41.222B 25.00
EssilorLuxottica Societe Anonyme (ESLOY) France $33.507B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.830B 18.71
Terumo (TRUMY) Japan $26.321B 32.85
Lonza Group Ag (LZAGY) Switzerland $25.591B 0.00
Coloplast (CLPBY) Denmark $25.229B 40.28
ResMed (RMD) United States $20.909B 38.57
Smith & Nephew SNATS (SNN) United Kingdom $18.758B 0.00
Sunny Optical Technology (SNPTF) China $17.275B 0.00
Insulet (PODD) United States $10.935B 520.23
Bio-Rad Laboratories (BIO) United States $10.601B 50.88
William Demant Holdings (WILYY) Denmark $6.665B 0.00
Perrigo (PRGO) Ireland $6.539B 12.19
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.074B 41.04
Canopy Growth (CGC) Canada $5.519B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.748B 29.51
ICU Medical (ICUI) United States $3.612B 23.55
Aurora Cannabis (ACB) Canada $3.385B 0.00
Neogen (NEOG) United States $3.373B 56.45
GW Pharmaceuticals (GWPH) United Kingdom $3.275B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.046B 0.00
Quidel (QDEL) United States $2.573B 24.42
National Vision Holdings (EYE) United States $2.139B 48.27
Agios Pharmaceuticals (AGIO) United States $2.014B 0.00
Cardiovascular Systems (CSII) United States $1.492B 0.00
InMode (INMD) Israel $1.468B 0.00
VAREX IMAGING (VREX) United States $1.144B 22.91
AtriCure (ATRC) United States $1.111B 0.00
Aphria (APHA) $1.109B 0.00
Phibro Animal Health (PAHC) United States $0.924B 17.30
NanoString Technologies (NSTG) United States $0.848B 0.00
Lantheus Holdings (LNTH) United States $0.838B 20.93
TG Therapeutics (TGTX) United States $0.794B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.777B 29.74
Omeros (OMER) United States $0.687B 0.00
PetIQ (PETQ) United States $0.686B 16.72
LeMaitre Vascular (LMAT) United States $0.679B 38.13
Quanterix (QTRX) United States $0.631B 0.00
Cerus (CERS) United States $0.609B 0.00
Surmodics (SRDX) United States $0.531B 55.41
HEXO (HEXO) $0.486B 0.00
OraSure Technologies (OSUR) United States $0.485B 29.07
Owens & Minor (OMI) United States $0.414B 15.30
MacroGenics (MGNX) United States $0.410B 0.00
Organigram Holdings (OGI) Canada $0.386B 0.00
Utah Medical Products (UTMD) United States $0.368B 26.68
Meridian Bioscience (VIVO) United States $0.366B 12.59
BioLife Solutions (BLFS) United States $0.302B 122.92
Zynex (ZYXI) United States $0.302B 34.11
Bovie Medical (APYX) United States $0.266B 0.00
Viemed Healthcare (VMD) United States $0.254B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.247B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Vapotherm (VAPO) United States $0.196B 0.00
Repro-Med Systems (KRMD) United States $0.170B 0.00
InfuSystems Holdings (INFU) United States $0.156B 789.00
Cytosorbents (CTSO) United States $0.138B 0.00
Rockwell Medical (RMTI) United States $0.134B 0.00
Fonar (FONR) United States $0.131B 9.23
Female Health (VERU) United States $0.125B 0.00
Chimerix (CMRX) United States $0.114B 0.00
Liberty Health Sciences (LHSIF) Canada $0.113B 0.00
United-Guardian (UG) United States $0.089B 22.60
Chembio Diagnostics (CEMI) United States $0.076B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.061B 0.00
Surface Oncology (SURF) United States $0.052B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.044B 0.00
MTech Acquisition (KERN) United States $0.042B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.022B 0.00
Senestech (SNES) United States $0.018B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.009B 0.00
Capricor Therapeutics (CAPR) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00